Attached files
| file | filename |
|---|---|
| EX-10.3 - EX-10.3 - SYNAGEVA BIOPHARMA CORP | d913483dex103.htm |
| EX-10.2 - EX-10.2 - SYNAGEVA BIOPHARMA CORP | d913483dex102.htm |
| EX-10.1 - EX-10.1 - SYNAGEVA BIOPHARMA CORP | d913483dex101.htm |
| EX-31.2 - EX-31.2 - SYNAGEVA BIOPHARMA CORP | d913483dex312.htm |
| EX-31.1 - EX-31.1 - SYNAGEVA BIOPHARMA CORP | d913483dex311.htm |
| EXCEL - IDEA: XBRL DOCUMENT - SYNAGEVA BIOPHARMA CORP | Financial_Report.xls |
| 10-Q - FORM 10-Q - SYNAGEVA BIOPHARMA CORP | d913483d10q.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002*
Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned, as principal executive officer and principal financial officer of Synageva BioPharma Corp. (the “Company”), does hereby certify that to such officer’s knowledge:
(1) the Company’s Form 10-Q for the period ended March 31, 2015 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Company’s Form 10-Q for the period ended March 31, 2015 fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /s/ Sanj K. Patel |
| Sanj K. Patel President and Chief Executive Officer |
| /s/ Carsten Boess |
| Carsten Boess Chief Financial Officer |
Date: April 30, 2015
| * | A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to Synageva BioPharma Corp. and will be retained by Synageva BioPharma Corp. and provided to the Securities and Exchange Commission or its staff upon request. |